PT  - JOURNAL ARTICLE
AU  - Harrieth P Ndumwa
AU  - Erick A Mboya
AU  - Davis Elias Amani
AU  - Ramadhani Mashoka
AU  - Paulina Nicholaus
AU  - Rashan Haniffa
AU  - Abi Beane
AU  - Juma Mfinanga
AU  - Bruno Sunguya
AU  - Hendry R. Sawe
AU  - Tim Baker
TI  - The burden of respiratory conditions in the emergency department of Muhimbili National Hospital in Tanzania in the first two years of the COVID-19 pandemic
AID  - 10.1101/2022.06.26.22276861
DP  - 2022 Jan 01
TA  - medRxiv
PG  - 2022.06.26.22276861
4099  - http://medrxiv.org/content/early/2022/06/27/2022.06.26.22276861.short
4100  - http://medrxiv.org/content/early/2022/06/27/2022.06.26.22276861.full
AB  - Background Globally, respiratory diseases cause 10 million deaths every year. With the COVID-19 pandemic, the burden of respiratory illness increased and led to significant morbidity and mortality in both high- and low-income countries. This study assessed the burden and trend of respiratory conditions among patients presenting to the emergency department of Muhimbili National Hospital in Tanzania and compared with national COVID-19 data to determine if this knowledge may be useful for the surveillance of disease outbreaks in settings of limited specific diagnostic testing.Methods The study used routinely collected data from the electronic information system in the Emergency Medical Department (EMD) of Muhimbili National Hospital in Tanzania. All patients presenting to the EMD in a 2-year period, 2020 and 2021 with respiratory conditions were included. Descriptive statistics and graphical visualizations were used to describe the burden of respiratory conditions and the trends over time and to compare to national Tanzanian COVID-19 data during the same period.Results One in every four patients who presented to the EMD of the Muhimbili National Hospital had a respiratory condition – 1039 patients per month. Of the 24,942 patients, 52% were males, and the median age (IQR) was 34.7 (21.7, 53.7) years. The most common respiratory diagnoses were pneumonia (52%), upper respiratory tract infections (31%), asthma (4.8%) and suspected COVID-19 (2.5%). There were four peaks of respiratory conditions coinciding with the four waves in the national COVID-19 data.Conclusions There is a high burden of respiratory conditions among patients presenting to the EMD of Muhimbili National Hospital. The trend shows four peaks of respiratory conditions in 2020-2021 seen to coincide with the four waves in the national COVID-19 data. Real-time hospital-based surveillance tools may be useful for early detection of respiratory disease outbreaks and other public health emergencies in settings with limited diagnostic testing.Competing Interest StatementTB declares a research grant and personal fees from the Wellcome Trust and personal fees from UNICEF, the World Bank, and USAID, all outside the submitted work. All other authors declare no conflict of interest.Funding StatementThis study was supported by the African critical care registry network for pandemic surveillance, clinical management and research (MRC/UKRI MR/V030884/1) and by the Laerdal Foundation.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethics committee/IRB of Muhimbili University of Health and Allied Sciences Ethical Review Board DA.282/298/06/C/767, MUHAS-REC-4-2020-217 and National Institute for Medical Research NIMR/HQ/R.8a/Vol.IX/3752 gave ethical approval for this workI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData can be made available upon reasonable request from the corresponding author.